YOLFTbeta
KDA Group Inc

KDA Group Inc

KDA · V · Healthcare / Health Information Services

0.05CAD+0.01 (+11.11%)

Price History

Full chart

Market Stats

Previous Close0.045
Open0.045
Day Range0.045 – 0.05
52-Week Range0.055 – 0.275
Volume87.17K
Market Cap14.10M
P/E (TTM)0.00
Forward P/E0.00
EPS-0.03
Dividend Yield0.00%
Beta0.99
50-Day Avg0.073
200-Day Avg0.1201

About

KDA Group Inc., together with its subsidiaries, provides technological and operational efficiency solutions for both the general and specialized health sectors in Canada. The company offers Adherize+, which is an intelligent patient engagement platform designed to monitor treatment adherence and provide tailored interventions; Medherize, a specialized module of Adherize+, focuses on patients undergoing complex therapies such as oral oncology treatments; KRx is an advanced electronic prescription platform for medical clinics; and CareMedic is digital health record and care coordination platform. The company was formerly known as AlliancePharma Inc. and changed its name to KDA Group Inc. in February 2017. KDA Group Inc. is headquartered in Thetford Mines, Canada.

Company Details

  • SectorHealthcare
  • IndustryHealth Information Services
  • CEOMr. Jean-Marc Leveille
  • Employees0
  • Headquarters1351, Notre Dame St. East, Thetford Mines, QC, Canada, G6G 0G5, Canada
  • Websitehttps://groupkda.com

Leadership

  • Mr. Marc LemieuxCo-Founder & Director
  • Ms. Isabelle BeginCo-Founder & Director
  • Mr. Michael Winslow Kinley C.A., C.P.A.CFO & Director · b. 1951
  • Mr. Jean-Marc LeveillePresident, CEO, Member of Strategic Advisory Board & Chairman
  • Ms. Marie-Helene PinardVP of Operations & COO Groupe Technologique KDA inc.
  • Dr. Giuseppe D'ApranoChief Scientific Officer
  • Mr. Michel GaudetteVP of Sales & Marketing
  • Mr. Yves MarmetMember of Strategic Advisory Board and President & CEO of Groupe Technologique KDA inc.
  • Ms. Annie MercierController
  • Mr. Pierre MonetSecretary

Financials

Income Statement

Currency: CAD2014-07-312015-07-312016-07-312017-07-312018-07-312019-07-312020-07-312021-07-312022-07-312023-07-312024-07-312025-07-31
Total Revenue3.80M5.52M7.70M30.25M23.29M23.09M22.89M24.36M28.82M161.12K147.42K165.40K
Growth (%)-+45.29%+39.56%+292.92%-23.02%-0.84%-0.88%+6.41%+18.33%-99.44%-8.51%+12.20%
Cost of Revenue2.78M4.35M6.53M22.51M14.99M17.54M17.03M17.17M20.76M01.43M2.93M
Gross Profit1.01M1.16M1.42M7.10M5.42M5.56M5.86M7.19M8.06M161.12K-1.29M-2.77M
Gross Margin26.71%21.10%18.38%23.48%23.27%24.06%25.62%29.52%27.97%100.00%-872.92%-1673.68%
Operating Expense295.40K1.62M2.79M8.06M4.50M6.00M5.95M5.55M6.60M3.47M3.35M6.18M
Operating Income718.96K-451.40K-1.38M-954.19K917.51K-441.61K-80.78K1.64M1.46M-3.31M-4.63M-8.94M
Operating Margin18.93%-8.18%-17.86%-3.15%3.94%-1.91%-0.35%6.73%5.08%-2053.85%-3142.31%-5407.78%
EBITDA----5.60M-1.91M-4.34M-1.47M836.50K-544.51K4.17M-4.23M-5.76M
EBITDA Margin----18.53%-8.20%-18.80%-6.40%3.43%-1.89%2589.82%-2866.86%-3483.74%
Net Income685.44K-1.28M-1.47M-8.02M-5.21M-8.52M-4.31M561.50K-4.56M16.14M-6.91M-8.05M
Net Income Margin18.05%-23.25%-19.07%-26.53%-22.38%-36.88%-18.83%2.31%-15.83%10015.99%-4686.11%-4866.30%
Interest Expense000002.52M2.80M14.21K3.48M1.39M167.75K94.00K
Interest Expense % of Total Revenue0.00%0.00%0.00%0.00%0.00%10.91%12.22%0.06%12.06%862.34%113.79%56.83%

Balance Sheet

Currency: CAD2014-07-312015-07-312016-07-312017-07-312018-07-312019-07-312020-07-312021-07-312022-07-312023-07-312024-07-312025-07-31
Total Assets799.89K6.56M6.97M31.72M23.71M16.09M19.91M22.20M28.67M21.86M13.39M11.25M
Total Liabilities2.21M6.31M7.83M30.88M27.94M22.67M23.57M18.29M28.87M5.36M1.67M2.04M
Total Equity-1.41M197.98K-879.64K834.83K-4.15M-6.16M-2.99M3.91M-202.91K16.51M12.50M10.87M
Cash243.68K510.00K164.14K289.83K972.02K1.23M1.81M1.72M2.74M4.63M1.65M133.79K
Net Debt----15.92M8.04M4.12M6.89M10.07M--516.21K

Cash Flow

Currency: CAD2014-07-312015-07-312016-07-312017-07-312018-07-312019-07-312020-07-312021-07-312022-07-312023-07-312024-07-312025-07-31
Operating Cash Flow466.51K-661.09K-642.13K-1.10M764.87K-2.35M-1.42M2.94M1.42M-844.02K-1.89M-2.36M
Investing Cash Flow-362.26K-2.88M-523.38K-13.65M269.42K2.52M-1.12M-3.10M-2.68M---
Financing Cash Flow2.97K3.81M819.65K14.88M-352.10K94.97K3.09M93.15K2.28M-9.79M128.72K2.21M
Capital Expenditure464.61K899130.55K23.71K327.41K393.59K97.42K48.13K45.42K2.12M2.10M1.36M
Free Cash Flow----1.35M226.29K-3.03M-2.35M444.04K-1.21M-2.96M-3.99M-3.73M
FCF to OCF---122.64%29.59%128.68%165.66%15.09%-85.54%350.60%211.22%157.59%

Earnings

Report DateJan 31, 2015Apr 30, 2015Jul 31, 2015Oct 31, 2015Jan 31, 2016Apr 30, 2016Jul 31, 2016Oct 31, 2016Jan 31, 2017Apr 30, 2017Jul 31, 2017Oct 31, 2017Jan 31, 2018Apr 30, 2018Jul 31, 2018Oct 31, 2018Jan 31, 2019Apr 30, 2019Jul 31, 2019Oct 31, 2019Jan 31, 2020Apr 30, 2020Jul 31, 2020Oct 31, 2020Jan 31, 2021Apr 30, 2021Jul 31, 2021Oct 31, 2021Jan 31, 2022Apr 30, 2022Jul 31, 2022Oct 31, 2022Jan 31, 2023Jul 6, 2023Nov 27, 2026
EPS Estimate-----------------------------------
EPS Actual-0.030.00-0.050.00-0.01-0.01-0.04-0.07-0.020.01-0.10-0.02-0.02-0.01-0.07-0.04-0.03-0.02-0.05-0.02-0.00-0.00-0.01-0.000.00-0.010.01-0.01-0.01-0.010.00-0.00-0.000.00-
Surprise-----------------------------------
Timing---------------------------------Pre-marketAfter-hours

Key Statistics & Ratios

Market Cap14.10M
Enterprise Value16.81M
Trailing P/E0.00
Forward P/E0.00
Price / Sales33.65
Price / Book2.75
EPS-0.03
Book Value0.025
Revenue (TTM)419.13K
Gross Profit (TTM)-2.95M
EBITDA-6.05M
Profit Margin0.00%
Operating Margin-1001.20%
Return on Equity-92.68%
Return on Assets-42.78%
Shares Outstanding235.05M
Shares Float170.74M
Beta0.99
Dividend Yield0.00%
Dividend Rate0.00
Payout Ratio0.00%